Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Experimental Iodized Salt With Lowerdose Folic Acid Fortification

Research Leaders

6 sponsors active, led by Ethiopian Public Health Institute

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Experimental Iodized Salt With Lowerdose Folic Acid Fortification1
  • Iodized Salt1
  • Experimental Iodized Salt With Higherdose Folic Acid Fortification1
  • Haemoglobin Measure1

Active Sponsors

  • Ethiopian Public Health Institute2
  • University of California, San Francisco2
  • Nutrition International2
  • University of California, Davis2
  • Institut Cancerologie de l'Ouest1

Top Investigators

Related Conditions

  • Folate Deficiency2
  • Salt Intake2
  • Anemia Macrocytic2
  • Iodine Deficiency2
  • Vitamin B 12 Deficiency1

Activity Timeline